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Purpose: The purpose of this article was to assess anumber of hematologic and fibrinolytic 
assays at the time of diagnosis of deep vein thrombosis (DVT) and at several intervals over 
a period of 6 months afterward and to correlate these results with the results of serial 
duplex scanning. 
Methods: Thirty-five patients (average age 61, range 18 to 82 ) with acute symptomatic DVT 
confirmed by duplex scanning were included. On diagnosis, blood was drawn, and plasma 
levels of tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor (PAI), 
D-dimer (DD), and tissue factor pathway inhibitor (TFPI) were determined. Duplex 
scanning and all laboratory assays were repeated i week, i month, 3 months, and 6 months 
thereafter. 
Results: The rate of DVT complete resolution 6 months after diagnosis was 57%. Whereas 
plasma levels of PAI were similar throughout he 6-month follow-up period, t-PA 
increased significantly I week after diagnosis and decreased thereafter. Both DD and TFPI 
levels decreased significantly after diagnosis compared with presentation values. Compar- 
ing these assay levels between patients with complete resolution versus partial or no 
resolution, PAI levels were significantly higher during the first week in patients with poor 
outcome. Plasma levels of t-PA were higher in cases with good outcome, and DD levels 
were higher in patients with poor outcome. TFPI levels were similar in both outcome 
groups. 
Conclusions: Patients with complete DVT resolution on duplex scanning at 6 months had 
significantly lower levels of PAI on presentation and after 1 week than did those with 
incomplete lysis. Although differences were not significant, -PA levels were higher and DD 
lower in patients with good outcome. Our results uggest that certain plasma fibrinolytic 
assays might correlate with the outcome of DVT, as assessed by duplex ultrasonography. 
(J VASC SURG 1996;23:616-21.) 
The natural history of deep vein thrombosis 
(DVT) is not fully understood. The final outcome of 
DVT depends on a balance between factors that 
promote further clot propagation or lead to its 
removal. ~Thrombus propagation is facilitated by 
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factors such as stasis, hypercoagulability, or vascular 
damage. On the other hand, a clot may be partially or 
completely removed by fibrinolytic enzymes or be- 
come organized and eventually recanalized by leuko- 
cytes, fibroblasts, and capillary proliferation. 2 
A number of investigators have assessed the fate of 
venous thrombi of the legs fbr several weeks after 
diagnosis by means of B-mode ultrasonography or
duplex scanning? -7Most of these studies have dem- 
onstrated that more than 50% of vein thrombi un- 
dergo complete resolution 3 to 6 months after diag- 
nosis. Some reports indicate that thrombi located 
distal to the knee joint are more easily lysed, 8whereas 
others howed faster esolution in proximal thrombi. 9
Yet other studies could not find significant differences 
in the rates of thrombus resolution among different 
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vein segments of the legs. 3'7 Other factors uch as age 
of the thrombus, clot extension, thrombus composi- 
tion, and amount of enzymatic activity have been 
suggested toinfluence thrombus outcome. ~~ 
A few studies have investigated the effect of 
anticoagulant therapy on a number of plasma markers 
of hemostatic activation and fibrinolysis in patients 
with documented DVT, with controversial re- 
suits, nq3 In this study, we prospectively assessed the 
evolution of plasma levels of plasminogen activator 
inhibitor (PAI), tissue-type plasminogen activator 
(t-PA), D-dimer (DD), and tissue factor pathway 
inhibitor (TFPI) at the time of DVT diagnosis and 
then at different intervals for 6 months. In addition, 
we tried to establish correlations between these 
plasma markers and long-term DVT outcome, as 
assessed by serial duplex scanning. 
METHODS 
Thirty-five patients (24 men and 11 women) 
referred to the vascular laboratory of our hospital 
with suspected DVT, in whom this diagnosis was 
confirmed, were included in the study. The protocol 
and consent form were approved by our hospital 
institutional review board. Average age of the pa- 
tients was 61 years (range 18 to 82). All patients were 
initially admitted with physical signs and symptoms 
suggestive of DVT, that is, leg pain, tenderness, and 
swelling. Two patients had bilateral thrombi. Ac- 
cordingly, there were 37 legs with DVT confirmed 
by duplex ultrasonography. In addition, 11 patients 
had confirmed pulmonary emboli, as detected by 
lung scanning. Twelve patients (34%) were already 
receiving intravenous heparin at the time of duplex 
examination. 
All patients received standard intravenous heparin 
treatment, given by continuous infusion, adjusted to 
prolong the activated partial thromboplastin time 
between 2.0 to 2.5 times the control. Oral anticoagu- 
lants were started after patients had received heparin 
for 5 to 10 days, at doses adjusted to target an 
international normalized ratio between 2.5 and 3, at 
least for 3 months. 
Duplex examinations were performed with an 
Ultramark 9 HDI color scanner (Advanced Technol- 
ogy Laboratories, Bothell, Wash.) on presentation 
and 1, 4, 12, and 24 weeks thereafter. Patients were 
placed in a 10- to 20-degree reverse Trendelenburg 
position to examine common femoral and superficial 
femoral veins. Popliteal, posterior tibial, and the 
remaining calf veins were studied with the leg in a 
dependent position. Images of all veins were obtained 
with transverse and longitudinal views. Abnormal 
criteria, indicative of DVT, included absence of both 
spontaneous and augmented Doppler signal, pres- 
ence of intraluminal echogenic filled material, inabil- 
ity to  compress vein with gentle probe pressure, and 
dilation of the thrombosed vein. The percentage of
obstruction of the vein lumen caused by the thrombus 
was calculated for each vein segment. 
Regarding DVT outcome, worsening was re- 
ported if the clot extended to vein segments previ- 
ously unaffected. No change indicated the presence of 
an unaltered clot. Improvement was reported if 
partial recanalization was evident, with reduction in 
the clot size, but with persistence of incomplete vein 
compression. A clot was considered to have resolved 
when the above-mentioned DVT criteria had disap- 
peared. 
Blood was gently drawn early in the morning by a 
double syringe technique and collected in citrated Va- 
cutainer (Becton Dickinson; Franklin Lakes, N.J.) 
tubes and centrifuged at 2000 g for 15 minutes at 
room temperature. Aliquots of plasma were stored at 
-70 ~ C for later use. The following enzyme immu- 
noassays were perfurmed: PAI-1 (Biopool Interna- 
tional, Ventura, Calif.), t-PA (Biopool), DD (Diag- 
nostica Stago; Asnieref, France), and TFPI (American 
Diagnostica, Greenwich, Conn.). All four assays were 
performed at the time of DVT diagnosis confirmation 
and repeated 1,4, 12, and 24 weeks thereafter. 
The values of the four assays were found to be 
normally distributed. Statistical analysis consisted of 
calculating the mean and standard eviation. Paired 
t testing was done for within-subject omparison of 
the blood tests at different time intervals compared to 
baseline. Independent S udent  testing was used to 
compare the blood assays results, depending on the 
outcome, at each time. The correlations between 
markers and age and among them were calculated by a 
linear regression model. Proportions were compared 
by the Fisher exact est. All tests were two-sided, and 
probability level of 0.05 or less was considered signifi- 
cant. These tests were carried out by use of the 
SPSS-PC software (SPSS Inc, Chicago, Ill.) run on an 
486DX2 IBM-compatible computer ~Packard-Bell; 
Chatsworth, Calif.). 
RESULTS 
On presentation, duplex scanning identified 19 
thrombi (51%) with 100% obstruction of the vein 
lumen. Proximal DVT, defined as above-knee joint, 
was reported in 29 patients (78%). 
The results of duplex examination, with regard to 
DVT outcome, are presented inTable I. There was a 
gradual improvement of the thrombotic process 
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Fig. 1. Evolution of PAI-1 levels during 6-month fol- 
low-up period in patients undergoing complete DVT reso- 
lution ("good") and in those who underwent incomplete 
or no thrombus resolution ("poor"). Values expressed as 
mean and SD (ng/ml). Comparison between two outcome 
groups at each time interval means of independent ttesting. 
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Fig. 2. Evolution oft-PA in patients admitted with DVT 
(See explanation i  Fig. 1). Values expressed as mean and 
SD (ng/ml). Independent t esting. 
throughout the study period. Six months after diag- 
nosis most thrombi had either resolved (57%) or 
improved (20%). On the contrary, 14% remained the 
same, and 8% had worsened. 
Patients were divided into two groups, depending 
on the results of duplex scanning obtained at 6 
months: (1) poor outcome, which means incomplete 
resolution (43%, 15 cases), and (2) good outcome, 
which indicates complete resolution (57%, 20 cases). 
There was not a statistically different outcome de- 
pending on the level of thrombosis on presentation 
Table I. DVT outcomc at diffi:rcnt 
time intervals 
Outcome 1 week 4 weeks 12 weeks 24 weeks 
Worse 3 (9%) 1 (3%) 2 (6%) 3 (9%) 
Nochange 15 (43%) 9 (26%) 5 (14%) 5 (14%) 
Improvement 16 (45%) 23 (66%)" 21 (60%) 7 (20%) 
Resolved 1 (3%) 2 (6%) 7 (20%) 20 (57%) 
(p = 0.97) or the prescnce of complete obstruction of 
the vein lumen (p = 0.23). 
There was not a statistically significant correlation 
between the administration of heparin at the time of 
the baseline duplex examination and the outcome, 
because 64% of patients who were not given heparin at 
the time of  diagnosis had good outcome, as compared 
with 54% in those receiving heparin (p = 0.39). On 
the other hand, 35% of patients receiving heparin on 
diagnosis had obstructive DVT, as compared to 77% 
of those who did not receive heparin (p < 0.01). A 
correct level of early anticoagulation (2 • control par- 
tial thromboplastin time) was achieved in 57% ofpa 
tients. In this group of patients uccessfully treated 
with anticoagulation, 65% of cases had good out- 
come, compared to 31% of patients with treated inap 
propriate anticoagulation who had good outcome 
(p = 0.06). We do not have enough data regarding 
international normalized ratio levels after hospital dis 
charge to correlate with final DVT outcome. 
Overall results of the plasma ssays, irrespective of 
the DVT outcome, are presented in Table II. Except 
for PAl, all the other marker levels experienced 
significant diftkrences during the tbllow-up determi- 
nations compared to baseline. 
A comparison of PAI levels in both outcome 
groups is shown in Fig. 1. Both on baseline and 1 week 
after DVT diagnosis, PAl levels were significantly 
higher in cases with poor final outcome. 
The t-PA levels were slightly higher on presenta- 
tion and during thc subsequent tblk~w-up in cases 
with good outcome, with significant diffi:rences only 
at the 4-week interval (Fig. 2 ). 1")D and TFPI showed 
similar levels in both outcome gtoups, with statistical 
diff~zrcnccs at 24 and 12 weeks, respectively (Figs. 3 
and 4). 
Depending on the proximal or distal location of 
the thrombi on baseline duplex scanning, a compari- 
son was perforlncd lor cach otthc |otJr plasma markers 
(Tablc III). Only 1)1) showed significantly higher 
levels in cases with proximal clots, on p.rcscntation 
(p<0.05)  and 1 aqd 24 weeks (p<0.05)  after 
diagnosis. Thc rest of the markers did not show 
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Fig. 3. Evolution of DD in patients presenting DVT (See 
explanation in Fig. 1). Values expressed as mean and SD 
(ng/ml). Independent t esting. 
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Fig. 4. Evolution of TFPI in patients with DVT (See 
explanation i Fig. 1). Values expressed as mean and SD 
(ng/ml). Independent t esting. 
statistically significant differences between proximal 
and distal clots. 
TFPI values were higher on presentation i pa- 
tients receiving heparin (150 ng/ml)  than in those 
who did not receive this drug (121 ng/ml);  however, 
this difference was not statistically significant 
(p= 0.14). PAI levels were significantly higher in 
patients receiving heparin on baseline testing (15.8 
ng/ml versus 14.8 ng/ml,  p < 0.05). Heparin did not 
significantly influence levels of t-PA or DD. No 
statistically significant correlations could be found 
between plasma markers and age, nor among them at 
the different intervals tudied. 
D ISCUSSION 
A newly developed venous thrombus induces 
prompt activation of the fibrinolytic system. In some 
cases, this plasminogcn-plasmin system will com- 
pletely dissolve the fresh clot early in the course of  the 
disease. This will depend on the age and size of the 
clot. Besides, almost from its formation, the clot 
undergoes a process of organization i itiated by white 
blood cells and endothelial cells. Most large clots 
cannot be completely removed by the fibrinolytic 
system and become organized as fibroblasts and 
capillarics proliferate within the thrombus. Then the 
clot may be incorporated into the vein wall or develop 
clefts as capillaries connect and form channels 
through which there is blood flow. This latter process 
is known as recanalization. 
Our main objective was to assess the long-term 
time-courses of a number of specit:ic markers of 
hemostasis and fibrinolysis in patients admitted with 
deep vein thrombosis and treated with standard 
anticoagulant treatment. Another objective was to 
correlate those markers with long-term DVT out- 
come. We selected two markers, t-PA and PAI; 
enzymes related to the activation and inhibition of  the 
plasminogen-plasmin system, respectively. On the 
other hand, DD is a fibrin degradation product being 
increasingly used for the diagnosis of DVT because 
the levels of DD are elevated in the presence of a 
thrombus. We decided to incorporate TFPI, a re- 
cently described serine protease synthesized by endo- 
thelial cells, into the panel of markers. TFPI is 
currently considered the factor Xa-dependent inhibi- 
tor of the tissue factor coagulation pathway and might 
play a key role in the action of heparin. 
Our results indicate that most patients howed 
improvement ofthe DVT process within the 6-month 
follow-up period. Similar results have been reported 
previously by us and by other investigators who also 
used ultrasonography. 37,14 In this study, DVT out- 
come has not been significantly influenced by thctors 
such as proximal extension of the clot or degree of 
vein obstruction caused by the thrombus on presen- 
tation. 
Both t-PA and PAI are derived from the endothe- 
lium. It is for that reason that a gentle blood-drawing 
technique, discarding the first 4 to 5 ml, is very 
important o prevent contamination of the sample 
caused by t-PA or PAl released from the vein wall at 
the site of  injection. Because there is evidence of 
fluctuations in the plasma levels of these markers 
during the 24-hour period, all blood extractions were 
done in the morning to prevent his influence. 
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Table II. Evolution of the different plasma markers during 6 months (mean + SD) 
Marker Baseline 1 week 4 ~,eeks 12 weeks 24 weeks 
PAI (ng /ml )  15.2 + 14 13.4 + 13 14.2 +_ 10 17.9 _+ 12 15.5 + 14 
t-PA (ng /ml )  14.3 + 6 21.5 -+ 8* 13.8 + 8 12.4 + 5* 11.5 +- 4" 
DD (ng /ml )  2230 -+ 1229 1784 + 840J" 751 _+ 450* 565 + 450* 620 + 660* 
TFPI  (ng /ml )  132 + 56 98.5 + 42* 78 -+ 22* 77.5 + 29* 77.6 • 23* 
*p < 0.01 paired t test compared to bascline. 
~fp < 0.05 paired t tes t  compared to baseline. 
Table I I I .  Evolution of the different plasma markers and level of DVT (mean + SD) 
Marker Level Baseline 1 week 4 weeks 12 weeks 24 weeks 
PAI Proximal 14.7 + 14 15.5 -+ 14 14.2-+ 11 21.1 -+ 12 17.5 + 15 
Distal 16.7 + 15 8.4 + 8 16.1 + 8 14.5 +- 11 15.3 + 10 
t-PA Proximal 15.3 + 6 22.3 + 8 14.1 + 8 " 13.2 + 5 11.4 + 4 
Distal 11.1 _+ 4 18.8 + 8 12.8 + 6 9.5 + 4 11.7 + 3 
DD Proximal 2241 _+ 1697 1789 + 697 803 + 481 550 + 470 655 + 749 
Distal 2190 -+ 1101 * 1766 + 1287" 582 + 314 620 + 419 512 + 324* 
TFPI  Proximal 134 + 54 102 _+ 44 83 + 22 81 + 31 82 + 24 
Distal 124 + 66 85 -+ 36 64 + 20 64 -+ 17 66 + 16 
*p < 0.05 independent  t test comparing proximal and distal. 
PAI levels did not experience significant changes 
after DVT diagnosis during the &month follow-up 
period. There was dramatic interindividual variation 
in the plasma levels of PAI, especially at presentation 
and after 1 week, as illustrated by the very high 
standard eviations hown in Table II. Plasma PAI 
levels were significantly higher, on baseline and 1 
week later, in patients with incomplete thrombus 
resolution. On the other hand, PAI levels were slightly 
higher in the good outcome group at 12 and 24 
weeks, but without statistically significant differences. 
A recent study has reported that ex vivo sponta- 
neous lysibility of  human thrombi was inversely re- 
lated to the amount of  PAI in the thrombus, m
Besides, PAI increase has been considered recently as 
a predictive factor of postoperative thromboembo- 
lism. ~s On the basis of  our results, it could be 
hypothesized that high plasma levels of PAI early after 
DVT diagnosis might indicate defective fibrinolysis of 
the newly formed clot, which will undergo aprocess of 
organization associated with incomplete resolution. 
However, on the basis of the number of cases included 
in this study, we realize that this hypothesis  prelimi- 
nary and should be validated in larger samples. We 
cannot explain why PM levels, on presentation, were 
significantly higher in patients who were receiving 
heparin. On the basis of  the comparisons mentioned 
above, we cannot attribute the difference to a signifi- 
cantly higher rate of proximal thrombi in patients 
already receiving heparin. Besides, as shown in Table 
III, PAI levels were similar in patients with proximal 
and distal thrombi throughout the study period. 
Plasma levels of t-PA increased significantly 
during the first week after DVT diagnosis, to decline 
to baseline values after 1 month. Then t-PA levels 
were gradually reduced 3 and 6 months thereafter. 
This marker was unable to distinguish patients under- 
going complete DVT resolution from those who did 
not. 
DD was increased at the time of DVT diagnosis, 
thus confirming previous reports demonstrating the 
value of this marker for the diagnosis ofDVT. ~6"~7 DD 
levels remained very high i week after DVT diagnosis 
and then were reduced to values slightly above 
normal. Similar esults have been recently reported by 
Elias et al. ~3 Our results do not show a different 
time-course of DD levels in patients with complete 
DVT resolution and in those with incomplete clot 
removal. However, arecent French trial showed that 
DD values were higher on presentation i patients 
with poor DVT outcome than in patients whose 
conditions improved or remained stationary. ~8 In 
contrast to some previous reports, ~we, as did others 
previously, ~8 have found a correlation between DD 
levels and the extent of venous thrombosis at presen- 
tation and during follow-up. 
TFPI was slightly increased at presentation and 
during the first week, decreasing subsequently to 
normal values. Such high levels of TFPI observed 
within the first week after DVT diagnosis could be 
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attributed to TFPI release induced by the heparin 
treatment, as previously reported/9,2~ However, we 
could not document significant diffkrences in TFPI 
levels at presentation i  patients receiving heparin and 
those who did not. On the other hand, there was not 
a correlation between TFPI levels and DVT outcome. 
Whereas ome studies have shown decreased levels of 
TFPI in patients with thromboembolic disease, 2~ 
others have reported similar plasma TFPI levels in 
patients with a positive phlebography result and in 
those with a negative phlebography result. 22 
In conclusion, this preliminary study shows that 
PAl levels, early in the course of DVT, could be related 
to thrombus outcome. The other plasma assays--t- 
PA, DD, and TFPI--were unable to diffkrentiate the 
patients who underwent a complete thrombus reso- 
lution, as assessed by duplex ultrasonography, from 
those who did not. These findings provide further 
insight into the process of thrombosis resolution and 
may help to identify those patients with poor prog- 
nosis. However, we realize that these preliminary data 
must be validated in a larger patient population. 
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